Thieno[2,3-d] pyrimidine as a promising scaffold in medicinal chemistry: Recent advances

被引:96
作者
Ali, Eslam M. H. [1 ,2 ]
Abdel-Maksoud, Mohammed S. [3 ]
Oh, Chang-Hyun [1 ,2 ]
机构
[1] KIST, Ctr Biomat, Seoul 02792, South Korea
[2] UST, Dept Biomol Sci, Daejeon 34113, South Korea
[3] NRC, Pharmaceut & Drug Ind Res Div, Med & Pharmaceut Chem Dept, Giza 12622, Egypt
关键词
Thienopyrimidine; Anti-inflammatory; Anticancer; Antimicrobial; Antiviral; CNS protective agents; RECEPTOR TYROSINE KINASE; INITIATION-FACTOR; 4E; BIOLOGICAL EVALUATION; DERIVATIVES BEARING; ANTICANCER ACTIVITY; 3-D PYRIMIDINE; THIENO; SUBSTITUTED THIENOPYRIMIDINES; STRUCTURAL MODIFICATIONS; ANTIBACTERIAL AGENTS;
D O I
10.1016/j.bmc.2019.02.044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thienopyrimidine scaffold is a fused heterocyclic ring system that structurally can be considered as adenine, the purine base that is found in both DNA and RNA-bioisosteres. Thienopyrimidines exist in three distinct isomeric forms. The current review discusses thieno[2,3-d] pyrimidine as a one of the opulent heterocycles in drug discovery. Its broad range of medical applications such as anticancer, anti-inflammatory, anti-microbial, and CNS protective agents has inspired us to study its structure-activity relationship (SAR), along with its relevant synthetic strategies. The present review briefly summarizes synthetic approaches for the preparation of thieno[2,3-d] pyrimidine derivatives. In addition, the promising biological activities of this scaffold are also illustrated with explanatory diagrams for their SAR studies.
引用
收藏
页码:1159 / 1194
页数:36
相关论文
共 168 条
[1]   New Potent SARS-CoV 3C-Like Protease Inhibitors Derived from Thieno[2,3-d]pyrimidine Derivatives [J].
Abd El-All, Amira S. ;
Atta, Sanaa M. Sh. ;
Roaiah, Hanaa M. F. ;
Awad, Enas M. ;
Abdalla, Mohamed M. .
ARCHIV DER PHARMAZIE, 2016, 349 (03) :202-210
[2]  
Akramov DK, 2016, AM CHEM SCI J, V2, P1
[3]   Thienopyrimidine derivatives exert their anticancer efficacy via apoptosis induction, oxidative stress and mitotic catastrophe [J].
Amawi, Haneen ;
Karthikeyan, Chandrabose ;
Pathak, Rekha ;
Hussein, Noor. ;
Christman, Ryann ;
Robey, Robert ;
Ashby, Charles R., Jr. ;
Trivedi, Piyush ;
Malhotra, Ashim ;
Tiwari, Amit K. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 :1053-1065
[4]   Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade [J].
Avruch, J ;
Khokhlatchev, A ;
Kyriakis, JM ;
Luo, ZJ ;
Tzivion, G ;
Vavvas, D ;
Zhang, XF .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 :127-155
[5]   Studies on novel D-ring substituted steroidal pyrazolines as potential anticancer agents [J].
Banday, Abid H. ;
Mir, Bilal P. ;
Lone, Imtiyaz H. ;
Suri, K. A. ;
Kumar, H. M. Sampath .
STEROIDS, 2010, 75 (12) :805-809
[6]   A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase [J].
Banerjee, T. ;
DuHadaway, J. B. ;
Gaspari, P. ;
Sutanto-Ward, E. ;
Munn, D. H. ;
Mellor, A. L. ;
Malachowski, W. P. ;
Prendergast, G. C. ;
Muller, A. J. .
ONCOGENE, 2008, 27 (20) :2851-2857
[7]   Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication [J].
Bassetto, Marcella ;
Leyssen, Pieter ;
Neyts, Johan ;
Yerukhimovich, Mark M. ;
Frick, David N. ;
Brancale, Andrea .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 123 :31-47
[8]  
Berndt A, 2010, NAT CHEM BIOL, V6, P117, DOI [10.1038/NCHEMBIO.293, 10.1038/nchembio.293]
[9]  
Borea PA, 2010, A3 ADENOSINE RECEPTORS FROM CELL BIOLOGY TO PHARMACOLOGY AND THERAPEUTICS, P29, DOI 10.1007/978-90-481-3144-0_2
[10]   N-[9-(ortho-Fluorobenzyl)-2-Phenyl-8-Azapurin-6-yl]-Amides as Potent and Selective Ligands for A1 Adenosine Receptors [J].
Borghini, Alice ;
Pietra, Daniele ;
Leonardi, Michele ;
Giorgi, Irene ;
Bianucci, Anna M. .
CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 82 (01) :22-38